BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6621771)

  • 1. Amphetamine-stimulated release of endogenous dopamine from the rat caudate nucleus in vivo.
    Philips SR; Robson AM
    Neurochem Res; 1983 Jun; 8(6):731-41. PubMed ID: 6621771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo release of endogenous dopamine from rat caudate nucleus by phenylethylamine.
    Philips SR; Robson AM
    Neuropharmacology; 1983 Nov; 22(11):1297-301. PubMed ID: 6664462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unstimulated and amphetamine-stimulated release of endogenous noradrenaline and dopamine from rat brain in vivo.
    Philips SR; Robson AM; Boulton AA
    J Neurochem; 1982 Apr; 38(4):1106-10. PubMed ID: 7062033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo release of endogenous dopamine from rat caudate putamen and nucleus accumbens by 40 mM potassium chloride.
    Philips SR
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):817-20. PubMed ID: 6686714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo.
    Chiueh CC; Moore KE
    J Pharmacol Exp Ther; 1975 Mar; 192(3):642-53. PubMed ID: 1120962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus.
    Patrick SL; Thompson TL; Walker JM; Patrick RL
    Brain Res; 1991 Jan; 538(2):343-6. PubMed ID: 2012977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo release of endogenous dopamine from rat caudate nucleus induced by amphetamine and other agents.
    Philips SR; Robson AM
    Ann N Y Acad Sci; 1986; 473():200-12. PubMed ID: 3467625
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine.
    Bailey BA; Philips SR; Boulton AA
    Neurochem Res; 1987 Feb; 12(2):173-8. PubMed ID: 2437473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ontogeny of amphetamine-induced dopamine release in the caudate-putamen of the rat.
    Gazzara RA; Fisher RS; Howard SG
    Brain Res; 1986 Aug; 393(2):213-20. PubMed ID: 3742239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine attenuates the stimulated release of dopamine in vivo.
    Kuhr WG; Ewing AG; Near JA; Wightman RM
    J Pharmacol Exp Ther; 1985 Feb; 232(2):388-94. PubMed ID: 3968641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylxanthine effects on caudate dopamine release as measured by in vivo electrochemistry.
    Morgan ME; Vestal RE
    Life Sci; 1989; 45(21):2025-39. PubMed ID: 2601563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of amphetamine on the in vivo release of dopamine, somatostatin and neuropeptide Y from rat caudate nucleus.
    Tatsuoka Y; Riskind PN; Beal MF; Martin JB
    Brain Res; 1987 May; 411(1):200-3. PubMed ID: 2886182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.
    Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
    Brain Res; 1987 Jan; 401(2):322-30. PubMed ID: 3815099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes.
    Carruba MO; Picotti GB; Zambotti F; Mantegazza P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):1-5. PubMed ID: 882144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the unilateral nigral application of dopaminergic drugs on the in vivo release of dopamine in the two caudate nuclei of the cat.
    Nieoullon A; Cheramy A; Leviel V; Glowinski J
    Eur J Pharmacol; 1979 Jan; 53(3):289-96. PubMed ID: 32060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo release of dopamine and its metabolites following a direct infusion of L-dopa into the caudate nucleus of awake, freely behaving rats using a push-pull cannula.
    Dluzen DE; Ramirez VD
    Neurosci Lett; 1987 Nov; 82(1):29-34. PubMed ID: 3122126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration.
    Ellison G; Eison MS; Huberman HS; Daniel F
    Science; 1978 Jul; 201(4352):276-8. PubMed ID: 26975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
    Chang GD; Ramirez VD
    Brain Res; 1987 Oct; 424(1):49-57. PubMed ID: 3319041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of haloperidol on amphetamine-induced increases in ascorbic acid and uric acid as determined by voltammetry in vivo.
    Mueller K; Haskett C
    Pharmacol Biochem Behav; 1987 Jun; 27(2):231-4. PubMed ID: 3628437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.